AbCellera Biologics Inc Share Price Today: Live Updates & Key Insights

AbCellera Biologics Inc share price today is $3.42, up -3.68%. The stock opened at $3.53 against the previous close of $3.53, with an intraday high of $3.585 and low of $3.395.

AbCellera Biologics Inc Share Price Chart

AbCellera Biologics Inc

us-stock
To Invest in {{usstockname}}
us-stock

AbCellera Biologics Inc Share Price Performance

$3.42 -0.0368(-3.68%) ABCL at 23 Mar 2026 11:51 AM Biotechnology
Lowest Today 3.395
Highest Today 3.585
Today’s Open 3.53
Prev. Close 3.53
52 Week High 6.52
52 Week Low 1.89
Day’s Range: Low 3.395 High 3.585
52-Week Range: Low 1.89 High 6.52
1 day return -
1 Week return -4.62
1 month return +12.02
3 month return -8.84
6 month return -29.46
1 year return +30.76
3 year return -53.42
5 year return -88.88
10 year return -

AbCellera Biologics Inc Institutional Holdings

Baker Bros Advisors LP 9.08

American Funds SMALLCAP World A 4.41

Capital World Investors 4.41

Two Sigma Investments LLC 1.92

Two Sigma Advisers, LLC 1.61

ArrowMark Colorado Holdings, LLC (ArrowMark Partners) 1.35

Driehaus Capital Management LLC 1.24

BlackRock Inc 1.20

UBS Lux Dgtl Hlth Eq Fd seeding P acc 0.97

Morgan Stanley - Brokerage Accounts 0.92

TANG CAPITAL MANAGEMENT LLC 0.86

UBS Group AG 0.82

Bank of America Corp 0.80

Renaissance Technologies Corp 0.79

ACATIS Datini Valueflex Fonds A 0.61

Citadel Advisors Llc 0.61

Tudor Investment Corp Et AL 0.59

Guardian Partners Inc. 0.59

Millennium Management LLC 0.59

iShares Biotechnology ETF 0.57

Susquehanna International Group, LLP 0.50

Jane Street Group LLC 0.46

VOLORIDGE INVESTMENT MANAGEMENT, LLC 0.23

State Street Corp 0.22

Heptagon Driehaus US Micro Cap Eq C$ Acc 0.21

State Street® SPDR® Ptf Dev Wld exUS ETF 0.18

iShares Genomics Immnlgy & Hlthcr ETF 0.12

BlackRock Advantage Small Cap Core Instl 0.11

SEB Artificial Intelligence D (USD) 0.11

iShares Healthcare Innov ETF USD Acc 0.09

Driehaus Micro Cap Growth USD 0.08

Driehaus Micro Cap Growth USD 0.08

iShares Nasdaq US Biotech ETF USD Acc 0.07

Lazard Digital Health 0.07

Acuitas US Microcap Strategy 0.06

Fidelity Nasdaq Composite Index 0.06

State Street® SPDR® S&P® Intl Sm Cp ETF 0.05

iShares Ageing Population ETF USD Acc 0.05

Fidelity Nasdaq Composite ETF 0.04

NT Quality Small Cap Value 0.04

AbCellera Biologics Inc Market Status

Strong Buy: 6

Buy: 2

Hold: 1

Sell: 0

Strong Sell: 0

AbCellera Biologics Inc Fundamentals

Market Cap 1030.75 M

PB Ratio 1.0676

PE Ratio 0.0

Enterprise Value 641.65 M

Total Assets 1356.95 M

Volume 2457069

AbCellera Biologics Inc Company Financials

Annual Revenue FY25:75128000 75.1M, FY23:50391000 50.4M, FY22:485424000 485.4M, FY21:11611543 11.6M, FY20:233155000 233.2M

Annual Profit FY25:null 0.0M, FY23:48837000 48.8M, FY22:418988000 419.0M, FY21:11611543 11.6M, FY20:206012000 206.0M

Annual Net worth FY25:-146412000 -146.4M, FY23:-129141000 -129.1M, FY22:158519000 158.5M, FY21:-2210696 -2.2M, FY20:118918000 118.9M

Quarterly Revenue Q4/2025:44852000 44.9M, Q3/2025:8955000 9.0M, Q2/2025:17084000 17.1M, Q1/2025:4235000 4.2M, Q3/2024:6507000 6.5M

Quarterly Profit Q4/2025:-59438000 -59.4M, Q3/2025:8955000 9.0M, Q2/2025:10025000 10.0M, Q1/2025:4235000 4.2M, Q3/2024:-31788000 -31.8M

Quarterly Net worth Q4/2025:-8945000 -8.9M, Q3/2025:-57119000 -57.1M, Q2/2025:-34727000 -34.7M, Q1/2025:-45621000 -45.6M, Q3/2024:-51107000 -51.1M

About AbCellera Biologics Inc & investment objective

Company Information AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; AbbVie Inc.; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.

Organisation Biotechnology

Employees 562

Industry Biotechnology

CEO Dr. Carl L.G. Hansen Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

AbCellera Biologics Inc FAQs

What is the share price of AbCellera Biologics Inc today?

The current share price of AbCellera Biologics Inc is $3.42.

Can I buy AbCellera Biologics Inc shares in India?

Yes, Indian investors can buy AbCellera Biologics Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy AbCellera Biologics Inc shares in India?

You can easily invest in AbCellera Biologics Inc shares from India by:

Can I buy fractional shares of AbCellera Biologics Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of AbCellera Biologics Inc?

AbCellera Biologics Inc has a market cap of $1030.75 M.

In which sector does AbCellera Biologics Inc belong?

AbCellera Biologics Inc operates in the Biotechnology sector.

What documents are required to invest in AbCellera Biologics Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of AbCellera Biologics Inc?

The PE ratio of AbCellera Biologics Inc is N/A and the PB ratio is 1.07.